₹3,414.2
▲ +4.09 +0.12%
18 Jul 2026
NSE Listed
Sanofi India Limited (SANOFI)
Volume: 16,991Avg Vol 1W: 32,555.6Avg Vol 1M: 24,632.352W Range:₹3,054₹6,044.5
Key Ratios
Checked 20h agoMarket Cap₹7,701 Cr
Current Price₹3,414.2
Previous Close₹3,410.11
High / Low (52w)₹6,044.5 / ₹3,054
Volume16,991
Avg Vol (1W)32,555.6
Avg Vol (1M)24,632.3
Stock P/E28.81
Book Value₹325.74
Dividend Yield—
ROE40.6%
ROA—
Revenue (TTM)₹1,857 Cr
Revenue Growth—
Profit Margin—
Total Debt₹0 Cr
Shares Outstanding—
Face Value₹10
EPS (TTM)₹142.04
P/B12.56
Debt / Equity0.02
50 DMA₹3,296.26
200 DMA₹3,861.84
Day change+0.12%
Price Chart
₹3,414.2▼ 42.83% · 1Y
2025-07-172026-07-16
20-day avg volume: 25K shares
Pros
- Healthy return on equity of 40.6%.
- Company is almost debt-free.
Quarterly Results
| Metric | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹737 Cr | ₹515 Cr | ₹491 Cr | ₹469 Cr | ₹511 Cr | ₹464 Cr | ₹524 Cr | ₹515 Cr |
| EBITDA | ₹246 Cr | ₹128 Cr | ₹115 Cr | ₹100 Cr | ₹132 Cr | ₹112 Cr | ₹113 Cr | ₹115 Cr |
| Net Profit | ₹190 Cr | ₹123 Cr | ₹152 Cr | ₹138 Cr | ₹137 Cr | ₹103 Cr | ₹82 Cr | ₹91 Cr |
| EPS | 82.67 | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 |
|---|---|---|---|---|---|
| Revenue | ₹2,992 Cr | ₹3,031 Cr | ₹2,842 Cr | ₹2,057 Cr | ₹2,030 Cr |
| EBITDA | ₹721 Cr | ₹770 Cr | ₹734 Cr | ₹512 Cr | ₹471 Cr |
| Net Profit | ₹478 Cr | ₹944 Cr | ₹621 Cr | ₹603 Cr | ₹413 Cr |
| EPS | 207.38 | 410.06 | 269.47 | 261.78 | 179.46 |
Balance Sheet
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 |
|---|---|---|---|---|---|
| Total Assets | ₹2,919 Cr | ₹3,061 Cr | ₹2,072 Cr | ₹1,715 Cr | ₹1,612 Cr |
| Total Liabilities | ₹800 Cr | ₹835 Cr | ₹796 Cr | ₹700 Cr | ₹751 Cr |
| Equity | ₹2,119 Cr | ₹2,226 Cr | ₹1,276 Cr | ₹1,015 Cr | ₹861 Cr |
| Total Debt | ₹0 Cr | ₹0 Cr | ₹0 Cr | — | — |
Cash Flow
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 |
|---|---|---|---|---|
| Operating | ₹844 Cr | ₹659 Cr | ₹472 Cr | ₹559 Cr |
| Investing | ₹631 Cr | ₹651 Cr | ₹38 Cr | ₹-19 Cr |
| Financing | ₹-849 Cr | ₹-1,583 Cr | ₹-878 Cr | ₹-392 Cr |
| Free Cash Flow | ₹844 Cr | ₹659 Cr | ₹472 Cr | ₹559 Cr |
Shareholding
Promoter 60.4% Institutions 26.77% Public 12.83%
Efficiency & Working Capital
ROCE54.2%
Interest Coverage313.7
Dividend Payout—
Debtor Days42 d
Inventory Days91 d
Payable Days74 d
Cash Conversion Cycle59 d
Working Capital Days132 d
Shareholding Details
As of 2026-03-31
Promoter60.4%
FII5.6%
DII21.1%
Institutions26.8%
Public12.8%
Promoter Pledge0%
No. of Shareholders75,758
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 60.4% | 60.4% | 60.4% | 60.4% | 60.4% | 60.4% | 60.4% | 60.4% | 60.4% | 60.4% | 60.4% | 60.4% |
| FIIs | 6.7% | 6.8% | 6.3% | 6.1% | 5.8% | 5.8% | 5.6% | 5.6% | 5.6% | 5.6% | 5.6% | 5.6% |
| DIIs | 19.7% | 21.7% | 22.5% | 23.1% | 22.8% | 22.8% | 22.9% | 23% | 23.1% | 22.3% | 21.3% | 21.1% |
| Public | 13.2% | 11.1% | 10.8% | 10.4% | 11% | 11% | 11% | 11% | 10.9% | 11.7% | 12.7% | 12.8% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 71,513 | 68,598 | 62,870 | 61,849 | 67,662 | 66,211 | 66,401 | 68,196 | 66,790 | 71,395 | 75,813 | 75,758 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202512 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Hoechst Gmbh | Shareholding of Promoter and Promoter Group | 60.4% | 1.39 Cr |
| Life Insurance Corporation Of India - P & Gs Fund | Public Shareholding | 6% | 13,69,833 |
| Nippon Life India Trustee Ltd-a/c Nippon India Small Cap Fund | Public Shareholding | 3.8% | 8,72,511 |
| General Insurance Corporation Of India | Public Shareholding | 2.6% | 5,89,887 |
| Aditya Birla Sun Life Trustee Private Limited A/c Aditya Birla Sun Life Mnc Fund | Public Shareholding | 2.4% | 5,47,335 |
| Sbi Midcap Fund | Public Shareholding | 2.3% | 5,18,543 |
| Hdfc Life Insurance Company Limited -shareholders Solvency Margin Account | Public Shareholding | 1.5% | 3,38,763 |
| Bajaj Life Insurance Limited | Public Shareholding | 1.4% | 3,16,667 |
| Sanofi | Shareholding of Promoter and Promoter Group | 0% | 4,865 |
| Sanofi Healthcare India Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Ckw Pharma Extrakt Beteiligungs Und Verwaltungs Gmbh | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Ckw Pharma Extrakt Gmbh & Co.kg | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Future Capital Ag Hessen Life Sciences Chemie | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Sanofi Aventis De Colombia S.a. | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Sanofi Aventis Deutschland Gmbh | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Starlink Logistics Inc. (slli) | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Aventis Agriculture | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Carraig Insurance Dac | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Euroapi | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Innobio 2 | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Le Rock Re | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Limited Liability Company Sanofi Aventis Ukraine | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Merieux Canada Holdings Ulc | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Sanofi Aventis De Colombia S.a. | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Sanofi Aventis Del Peru S.a. | Shareholding of Promoter and Promoter Group | 0% | 0 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Sanofi Healthcare India Private Limited | 0 | 0% | 2026-03-31 |
| Sanofi | 0 | 0% | 2026-03-31 |
| Hoechst Gmbh | 0 | 0% | 2026-03-31 |
| Ckw Pharma Extrakt Beteiligungs Und Verwaltungs Gmbh | 0 | 0% | 2026-03-31 |
| Ckw Pharma Extrakt Gmbh & Co.kg | 0 | 0% | 2026-03-31 |
| Future Capital Ag Hessen Life Sciences Chemie | 0 | 0% | 2026-03-31 |
| Sanofi Aventis De Colombia S.a. | 0 | 0% | 2026-03-31 |
| Sanofi Aventis Deutschland Gmbh | 0 | 0% | 2026-03-31 |
| Starlink Logistics Inc. (slli) | 0 | 0% | 2026-03-31 |
| Aventis Agriculture | 0 | 0% | 2026-03-31 |
| Carraig Insurance Dac | 0 | 0% | 2026-03-31 |
| Euroapi | 0 | 0% | 2026-03-31 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Vaibhav KARANDIKAR | Non Executive Director | 2025 |
| Rahul Bhatnagar | Chairman | 2025 |
| Eric Mansion | Non Executive Director | 2025 |
| Rachid Ayari | Executive Director / Whole Time Director / CFO | 2025 |
| Mahadev Gawade | Whole-time Director | 2025 |
| DEEPAK ARORA | Managing Director | 2025 |
| Sudipta Chakraborty | Whole-time Director | 2025 |
| Rajani Kesari | Independent Director | 2025 |
| SIRAJ AZMAT CHAUDHRY | Independent Director | 2025 |
| HARESH BACHUBHAI VALA | Company Sec. & Compli. Officer | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Pharmaceutical Products | ₹0 Cr | — |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| India | ₹1,593 Cr | 86.7% |
| Singapore | ₹231 Cr | 12.6% |
| Others | ₹14 Cr | 0.8% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 24 | 23 | 23 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| dividend | 2026-04-22 | ₹48 (480%) | Final |
| dividend | 2025-11-07 | ₹75 (750%) | Interim |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2024 | 76 | 0 | 0 | 11 | 1,234 | 1,554 |
| 2024 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 26 | 0 | 0 | 1 | 6 | 32 |
Substantial Acquisitions (SAST)
1 disclosure(s)
Market27/10/2021 · 5,094
Company Information
Incorporated1956
ChairmanRahul Bhatnagar
AuditorPrice Waterhouse Chartered Accountants LLP
Investor Email[email protected]
📍 Sanofi Hse 117-B Saki Vihar Rd, L&T Business Park Powai, Mumbai, Maharashtra, 400072
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Sandhar Technologies Ltd.Sandur Mang & Iron Ores LimitedSangam (India) Ltd.Sangani Hospitals LimitedSanghvi Movers Ltd.Sanginita Chemicals Ltd.Sanofi Cons Healthc Ind LimitedSansera Engineering Ltd.Sanstar LimitedSanwaria Consumer LimitedSapphire Foods India Ltd.Shree Ajit Pulp & Paper LimitedAll “S” stocks →
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search